Relmada Therapeutics Inc. (NASDAQ: RLMD) Stock Information | RedChip
Image

ASK REDCHAT® ANYTHING ABOUT RELMADA THERAPEUTICS INC.

Relmada Therapeutics Inc. (NASDAQ: RLMD)
Listen to this Section


$0.33
-0.0143 ( -1.27% ) 10.6K

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

Market Data


Open $0.33
Previous Close $0.34
Volume 10.6K
Market Cap $10.26M
Day Range $0.33 - $0.36
52 Week Range $0.31 - $7.22
Shares Outstanding 30.17M
Change % -1.27%
Net Change ▼ -0.0143
Insider Ownership 0.01%
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology: Pharmaceutical Preparations
IPO Year 2014
Country United States

Insider Ownership Transactions

Total Amount Purchased: -691,619.00

Date Type Amount Purchased Purchaser
2024-09-11 Buy 8194.00 Shenouda Maged
2024-09-11 Buy 25000.00 Kelly Paul Edward
2024-09-11 Buy 55579.00 TRAVERSA SERGIO
2024-09-11 Buy 13000.00 CASAMENTO CHARLES J
2024-05-29 Sale -54624.00 Ence Chuck
2024-05-29 Sale -122358.00 TRAVERSA SERGIO
2024-05-29 Sale -43700.00 Kelly Paul Edward
2024-05-29 Sale -20976.00 GLASSPOOL JOHN
2024-05-29 Sale -54624.00 Shenouda Maged
2024-05-29 Sale -20976.00 Fedeli Fabiana

Institutional Ownership

Total Market Value $ 0.00

Symbol Issuer Name Market Value ↓ Share Quantity
No records found.

SEC Fillings


Form Type Description Pages Date
sc Insider transactions 1 Feb 14, 2024
sc Insider transactions 1 Feb 14, 2024
sc Insider transactions 1 Feb 13, 2024

Latest News


× Before browsing our site, please accept our cookies policy